The effect of nonsteroidal anti-inflammatory drugs on oxidative/ antioxidative balance;Wpływ wybranych niesteroidowych leków przeciwzapalnych na równowage oksydacyjno/antyoksydacyjna

Polski Merkuriusz Lekarski

Volumn 23, Issue 135, 2007, Pages 184-187

  Kopff, Maria ^a   Kopff, Anna ^a   Kowalczyk, Edward ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Nonsteroidal anti inflammatory drugs; Oxidative antioxidative balance

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; SULFONAMIDE;

ANIMAL; ARTICLE; DRUG EFFECT; FEMALE; MALE; OXIDATIVE STRESS; RAT; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DICLOFENAC; FEMALE; MALE; OXIDATIVE STRESS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SULFONAMIDES;

EID: 35048882974     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Benzie I.F., Strain J.J.: The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem., 1996, 239, 70.
2. Bonnefont J., Courade J.P., Alloui A. i wsp.: Antinoceptive mechanism of action of paracetamol. Drugs, 2003, 63, spec. no 2, 1.
3. Botting R., Ayoub S.S.: COX-3 and mechanism of action of paracetamol/ acetaminophen. Prostaglandins Leukot. Essent. Fatty Acids, 2005, 72, 85.
4. Chandrasekharan N.V., Dai H., Roos K.L. i wsp.: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proc. Natl. Acad. Sci., USA, 2002, 99, 13926.
5. Cryer B., Feldman M.: Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatorey drugs. Am. J. Med., 1998, 104, 413.
6. De Zwart L.L., Meerman J.H., Commandeur J.N. i wsp.: Biomarkers of free radical damage applications in experimental animals and in humans. Free Rad. Biol. Med., 1999, 26, 202.
7. Ellman G.L.: Tissue sulfhydryl groups. Arch. Biochem. Biophys., 1959, 82, 70.
8. Famaey J.P.: In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Inflamm. Res., 1997, 46, 437.
9. Hermann M., Camici G., Fratton A. i wsp.: Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt - induced hypertension. Circulation, 2003, 108, 2308.
10. Hersh E.V., Lally E.T., Moore P.A.: Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray? Curr. Med. Res. Opin., 2005, 8, 1217.
11. Hickey E.J., RaJe R.R., Reid V.E. i wsp.: Diclofenac induced in vivo nephrotoxicity may involve oxidative stress - mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic. Biol. Med., 2001, 31, 139.
12. Katusic Z.S., Schugel J., Cosentino F., Vanhoutte P.M.: Endothelium-dependent contractions to oxygen-derived free radicals in the canine basilar artery. Am. J. Physiol., 1993, 264, H 859.
13. Khan J., Brennand D.M., Bradley N. i wsp.: 3-nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J., 1998, 332, 807.
14. Kis B., Snipes A., Bari F., Busija D.W.: Regional distribution of cyclooxygenase-3 mRNA in rat central nervous system. Brain Res. Mol. Brain Res., 2004, 126, 78.
15. Kopff M., Kowalczyk E., Kopff M.: Influence of selected cardiological drugs on oxidative status. Polish J. Pharmacol., 2004, 56, 265.
16. Kujubu D.A., Fletcher B.S., Varnum B.C. i wsp.: TIS 10, a phorbol ester tumor promoter- inducible m-RNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 1991, 266, 12866.
17. Liczmański A.E.: Toksyczność tlenu. Mechanizmy obronne. Post. Bioch., 1988, B, 34, 293.
18. Loll PJ., Picot D., Garavito R.M.: The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat. Struct. Biol., 1995, 2, 637.
19. Maffei Facino R., Carini M., Aldini G. i wsp.: Differential inhibition of superoxide, hydroxyl and peroxyl radicals by nimesulide and its main metabolite 4-hydroxynimesulide. Arzneimittelforschung, 1995, 45, 1102.
20. Mouithys-Mickalad A.M., Zheng S.X., Deby-Dupont G.P. i wsp.: In vitro study of the antioxidant properties of non steroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR). Free Radic Res., 2000, 33, 607.
21. Orhan H., Marol S., Hepsen I.F., Sahin G.: Effects of some probable antioxidant on selenite - induced cataract formation and oxidative stress - related parameters in rats. Toxicology, 1999, 139, 219.
22. Rehman Q., Sack K.E.: Kiedy stosować wybiórcze inhibitory COX-2. Med. po Dypl., 2000, 9, 39.
23. Rice-Evans C.A., Diplock A.T., Symons M.C.R.: Techniques in Free Radicals Research. Ed. Burdon R.H., Knippenberg P.H., Elsevier, Amsterdam, London, New York, Tokyo, 1991.
24. Roth G.J., Majerus P.W.: The mechanism of the effect of aspirin on human platelets. In: Acetylation of a participate fraction protein. J. Clin. Invest., 1975, 56, 624.
25. Smith W.L.: Prostanoid biosythesis and mechanism of action. Am. J. Physiol., 1992, 263, F181.
26. Ter Steege J.C., Koster-Kamphuis L., van Straaten E.A. i wsp.: Nitrotyrosine in plasma of celiac disease patient as detected by a new sandwich ELISA. Free Radic. Biol. Med., 1998, 25, 953.
27. Vane J.R., Bakhle Y.S., Botting R.M.: Cyclooxygenase 1 and 2. Annu. Rev. Pharmacol.Toxicol., 1998, 38, 97.
28. Vane J.R.: Inhibition of prostaglandin synthesis as a mechanism of action for aspiryn-like drugs. Nat. New Biol., 1971, 231, 233.
29. Williams C.S., Du Bois R.N.: Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol., 1996, 270, G393.
30. Wu R., de Champlain J.: Aspirin treatment decreases aortic tissue and cultured aortic smooth muscle cells superoxide production and NAD(P)H oxidase activity in rats. Can. Cardiovasc. Congress, 2001, Abstracts 203
31. Wu R., Lamontagne D., de Champlain J.: Antioxidative properties of acetylsalicylic acid on vascular tissue from normotensive and spontaneusly hypertensive rats. Circulation, 2002, 105, 387.
32. Xie W.L., Chipman J.G., Robertson D.L. i wsp.: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA, 1991, 88, 2692.